Abstract
Lymphoplasmacytic sclerosing pancreatitis (LP) is a rare cause of benign mass lesions of the pancreas that can resemble adenocarcinoma. This study evaluates and classifies a series of patients with LP. Patients with benign pancreatic disease were identified from a prospective pancreatic database, and these cases were reviewed to identify patients with LP. Patients were subdivided into two groups: (1) classic LP, which included those patients who had all four of the characteristic histologic features of LP, including lymphoplasmacytic infiltration of the pancreas, interstitial fibrosis, periductal inflammation, and peri-phlebitis; and (2) intermediate LP, which included patients with at least two of these histologic findings. Patient demographics, pathologic and clinical features, and outcome were analyzed. From 1985 to 2001, a total of 1287 pancreatic resections were performed at our institution, of which 159 were for benign disease. Of these, 31 had pathologic features consistent with LP, and all of these patients had a presumed preoperative diagnosis of pancreatic carcinoma. Most of these patients presented with jaundice (n = 21) or abdominal pain (n = 7). In 29 of 31 patients, curative resection was possible. Of these, 28% (8/29) developed recurrence after resection: seven with jaundice and one with recurrent pancreatitis (median time to recurrence, 11 months; median follow up, 38 months). All patients with recurrent jaundice appeared to have biliary strictures at the time of direct cholangiography and no patient had malignancy. A review of the pathology reports identified 19 patients with classic LP and 12 patients with intermediate LP, and there was no difference between these two groups. LP is a rare cause of pancreatitis that is difficult to differentiate from carcinoma preoperatively. Patients with classic and intermediate LP appear to demonstrate a similar clinical behavior. Nearly one third of patients have a progressive course after resection, with 25% developing recurrent jaundice; thus close follow-up is mandatory for all patients.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Barreda F, Contardo C, Leon A, Navarrete J, Figueroa R, Attanasio F. [Primary sclerosing cholangitis associated with Sjögren’s syndrome, retroperitoneal fibrosis and chronic pancreatitis. Report of a case.]Rev Gastroenterol Peru 1989;9:106–114.
Kawaguchi K, Koike M, Tsuruta K, Okamoto A, Tabata I, Fujita N. Lymphoplasmacytic sclerosing pancreatitis with cholangitis: A variant of primary sclerosing cholangitis extensively involving pancreas. Hum Pathol 1991;22:387–395.
Montefusco PP, Geiss AC, Bronzo RL, Randall S, Kahn E, McKinley MJ. Sclerosing cholangitis, chronic pancreatitis, and Sjögren’s syndrome: A syndrome complex. Am J Surg 1984;147:822–826.
Nieminen U, Koivisto T, Kahri A, Farkkila M. Sjögren’s syndrome with chronic pancreatitis, sclerosing cholangitis, and pulmonary infiltrations. Am J Gastroenterol 1997;92:139–142.
Sood S, Fossard DP, Shorrock K. Chronic sclerosing pancreatitis in Sjögren’s syndrome: A case report. Pancreas 1995;10:419–421.
Hamano H, Kawa S, Horiuchi A, Unno H, Furuya N, Aka-matsu T, Fukushima M, Nikaido T, Nakayama K, Usuda N, Kiyosawa K. High serum IgG4 concentrations in patients with sclerosing pancreatitis. N Engl J Med 2001;344:732–738.
Yoshida K, Toki F, Takeuchi T, Watanabe S, Shiratori K, Hayashi N. Chronic pancreatitis caused by an autoimmune abnormality. Proposal of the concept of autoimmune pancreatitis. Dig Dis Sci 1995;40:1561–1568.
Taniguchi T, Seko S, Azuma K, Asagoe K, Tamegai M, Nishida O, Inoue F, Okamoto M, Mizumoto T, Kobayashi H. Autoimmune pancreatitis detected as a mass in the head of the pancreas with contiguous fibrosis around the superior mesenteric artery. Dig Dis Sci 2001;46:187–191.
Ito T, Nakano I, Koyanagi S, Miyahara T, Migita Y, Og-oshi K, Sakai H, Matsunaga S, Yasuda O, Sumii T, Nawata H. Autoimmune pancreatitis as a new clinical entity. Three cases of autoimmune pancreatitis with effective steroid therapy. Dig Dis Sci 1997;42:1458–1468.
Furukawa N, Muranaka T, Yasumori K, Matsubayashi R, Hayashida K, Arita Y. Autoimmune pancreatitis: Radiologic findings in three histologically proven cases. J Comput Assist Tomogr 1998;22:880–883.
Irie H, Honda H, Baba S, Kuroiwa T, Yoshimitsu K, Tajima T, Jimi M, Sumii T, Masuda K. Autoimmune pancreatitis: CT and MR characteristics. AJR Am J Roentgenol 1998;170:1323–1327.
Van Hoe L, Gryspeerdt S, Ectors N, Van Steenbergen W, Aerts R, Baert AL, Marchal G. Nonalcoholic duct-destructive chronic pancreatitis: Imaging findings. AJR Am J Roentgenol 1998; 170:643–647.
Frulloni L, Morana G, Bovo P, Mansueto GC, Vaona B, Di Francesco V, Procacci C, Cavallini G. Salivary gland involvement in patients with chronic pancreatitis. Pancreas 1999;19:33–38.
Borum M, Steinberg W, Steer M, Freedman S, White P. Chronic pancreatitis: A complication of systemic lupus erythematosus. Gastroenterology 1993;104:613–615.
Stathopoulos G, Nourmand AD, Blackstone M, Andersen D, Baker AL. Rapidly progressive sclerosing cholangitis following surgical treatment of pancreatic pseudotumor. J Clin Gastroenterol 1995;21:143–148.
Kazumori H, Ashizawa N, Moriyama N, Arima N, Hirakawa K, Adachi K, Watanabe M, Kinoshita Y, Tamura K. Primary sclerosing pancreatitis and cholangitis. Int J Pancreatol 1998;24:123–127.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Weber, S.M., Dimopulo, O.C., Palesty, J.A. et al. Lymphoplasmacytic sclerosing pancreatitis: Inflammatory mimic of pancreatic carcinoma. J Gastrointest Surg 7, 129–139 (2003). https://doi.org/10.1016/S1091-255X(02)00148-8
Published:
Issue Date:
DOI: https://doi.org/10.1016/S1091-255X(02)00148-8